Inhibitors of collagen biosynthesis as a means of controlling scar formation in tendon injury.
D000629:Aminopropionitrile / Q000627:therapeutic use* / Q000633:toxicity; D000818:Animals; D002614:Chelating Agents / Q000627:therapeutic use* / Q000633:toxicity; D002921:Cicatrix / Q000517:prevention & control*; D003094:Collagen / Q000096:biosynthesis*; D006614:Hindlimb; D006909:Hydroxyproline / Q000627:therapeutic use* / Q000633:toxicity; D010396:Penicillamine / Q000627:therapeutic use* / Q000633:toxicity; D011725:Pyridines / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats; D013708:Tendon Injuries / Q000150:complications*; D000267:Tissue Adhesions / Q000517:prevention & control*; D014945:Wound Healing / Q000187:drug effects*
D002614:Chelating Agents; D011725:Pyridines; D000629:Aminopropionitrile; D003094:Collagen; D010396:Penicillamine; D006909:Hydroxyproline